Small RNA characterization of urinary exosomes, new PO
Ended Purchase Order Awarded
- Contract number
- 75N92025P00384
- Awardee
-
Norgen Biotek Corp UEI SB5ZH66FTV27
- Awarding agency
-
National Heart Lung and Blood Institute
National Institutes of Health, Department of Health and Human Services
- Obligated
- $156,600
Award facts
- Opportunity
-
- Small RNA characterization of urinary exosomes Solicitation · 75N92025Q00112 · Posted Aug 18, 2025
- Contract value 100% obligated
- $156,600.00 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- Funding agency
- National Human Genome Research Institute National Institutes of Health, Department of Health and Human Services
- NAICS code
- 541380 Testing Laboratories and Services
- PSC
- Q301 Reference Laboratory Testing
- Set-aside
- No set-aside
- Competition
- Competed under SAP · 4 offers Simplified Acquisition
- Pricing
- Firm Fixed Price
- Place of performance
- Bethesda, MD 20892, USA
Award details come from SAM.gov/FPDS.
About this award
The National Human Genome Research Institute (NHGRI), part of the National Institutes of Health under the Department of Health and Human Services, awarded a $156,600 firm fixed-price purchase order to Norgen Biotek Corp for small RNA characterization of urinary exosomes. This is a new purchase order with no set-aside designation, making it open to competition among all qualified contractors. Work will be performed at Norgen Biotek's facilities in Bethesda, Maryland, with an ultimate completion date of September 18, 2026. The contract was awarded on September 19, 2025, following a solicitation posted August 18, 2025, with a ten-day response deadline, indicating an accelerated procurement timeline.
Norgen Biotek Corp, a Canadian for-profit biotechnology manufacturer, is well-positioned to execute this work based on its extensive history providing exosome and extracellular RNA extraction, isolation, purification, and sequencing services to NIH institutes. The company has received over $1 million in prior federal purchase orders from NHGRI and the National Institute of Diabetes and Digestive and Kidney Diseases for similar RNA exosome work, with individual awards ranging from approximately $16,000 to $669,000. This new contract represents continued engagement with NHGRI to support advanced RNA sequencing and urinary biomarker research initiatives, with no subcontractors identified on this award.
Quick answers
Who was awarded contract 75N92025P00384?
75N92025P00384 was awarded to Norgen Biotek Corp by National Heart Lung and Blood Institute (National Institutes of Health) on September 19, 2025.
How much is contract 75N92025P00384 worth?
The government has obligated $156,600 on 75N92025P00384.
Which agency awarded contract 75N92025P00384?
National Heart Lung and Blood Institute (National Institutes of Health) awarded 75N92025P00384, with funding from National Human Genome Research Institute (National Institutes of Health).
Was contract 75N92025P00384 competed?
The extent of competition for 75N92025P00384 was competed under sap. The government received 4 offers.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award